← Back to Clinical Trials
Recruiting NCT06038019

NCT06038019 Thresholds In Food Allergy evaluaTion And predictioN

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06038019
Status Recruiting
Phase
Sponsor Hamilton Health Sciences Corporation
Condition Tree Nut Allergy
Study Type OBSERVATIONAL
Enrollment 2,000 participants
Start Date 2023-11-01
Primary Completion 2050-11-01

Eligibility & Interventions

Sex All sexes
Min Age 3 Months
Max Age 65 Years
Study Type OBSERVATIONAL
Interventions
Oral food challenge

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 2,000 participants in total. It began in 2023-11-01 with a primary completion date of 2050-11-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Thresholds In food allergy evaluaTion And predictioN, a prospective, observational registry. The aim is to quantify food allergy thresholds in Canada and their clinical predictors.

Eligibility Criteria

Inclusion Criteria: 1. Suspicion or history of food allergy based on medical history, positive skin prick test, and/or serum food-specific IgE. A suggestive history is defined as typical clinical signs and/or symptoms (urticaria, angioedema, abdominal pain, vomiting, dyspnea, wheeze) within 60 minutes of the ingestion of a food. 2. Ability to discontinue all antihistamines for 1 week before oral food challenge. Exclusion Criteria: 1. Previous desensitization treatment to a food allergen 2. Allergies to any component of the oral challenge vehicle 3. Unstable conditions including uncontrolled asthma or chronic urticaria 4. Any clinically significant disease/chronic medical condition which may interfere with study evaluations.

Contact & Investigator

Central Contact

Heather Le

✉ lehea@hhsc.ca

📞 905-525-9140

Principal Investigator

Derek Chu, MD PhD FRCPC

PRINCIPAL INVESTIGATOR

Hamilton Health Sciences & McMaster University

Frequently Asked Questions

Who can join the NCT06038019 clinical trial?

This trial is open to participants of all sexes, aged 3 Months or older, up to 65 Years, studying Tree Nut Allergy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06038019 currently recruiting?

Yes, NCT06038019 is actively recruiting participants. Contact the research team at lehea@hhsc.ca for enrollment information.

Where is the NCT06038019 trial being conducted?

This trial is being conducted at Hamilton, Canada.

Who is sponsoring the NCT06038019 clinical trial?

NCT06038019 is sponsored by Hamilton Health Sciences Corporation. The principal investigator is Derek Chu, MD PhD FRCPC at Hamilton Health Sciences & McMaster University. The trial plans to enroll 2,000 participants.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology